Chapman‐Rothe, N.

H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study

Maurer, M., Staubach, P., Raap, U., Richter‐Huhn, G., Bauer, A., Ruëff, F., Jakob, T., Yazdi, A. S., Mahler, V., Wagner, N., et al. (2017) · Clinical & Experimental Allergy

Urticaria and Related ConditionsMast cells and histamine

Cited by 131

Effect of omalizumab on angioedema in H 1 ‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ ACT , a randomized controlled trial

Staubach, P., Metz, M., Chapman‐Rothe, N., Sieder, C., Bräutigam, M., Canvin, J., & Maurer, M. (2016) · Allergy

Urticaria and Related ConditionsMast cells and histamine

Cited by 130

Increased efficacy of omalizumab in atopic dermatitis patients with wild‐type filaggrin status and higher serum levels of phosphatidylcholines

Hotze, M., Baurecht, H., Rodríguez, E., Chapman‐Rothe, N., Ollert, M., Fölster‐Holst, R., Adamski, J., Illig, T., Ring, J., & Weidinger, S. (2014) · Allergy

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 107

Antihistamine‐resistant chronic spontaneous urticaria: 1‐year data from the AWARE study

Maurer, M., Raap, U., Staubach, P., Richter‐Huhn, G., Bauer, A., Oppel, E. M., Hillen, U., Baeumer, D., Reinhardt, M., & Chapman‐Rothe, N. (2019) · Clinical & Experimental Allergy

Urticaria and Related ConditionsMast cells and histamine

Cited by 74

Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data

Staubach, P., Metz, M., Chapman‐Rothe, N., Sieder, C., Bräutigam, M., Maurer, M., & Weller, K. (2018) · Allergy

Urticaria and Related ConditionsMast cells and histamine

Cited by 65